Core Viewpoint - The Gross Law Firm has announced a class action lawsuit against BlackRock TCP Capital Corp. (NASDAQ: TCPC) for allegedly issuing misleading statements and failing to disclose critical information regarding the company's investments and financial health during the specified class period [2]. Group 1: Allegations and Class Period - The class period for the lawsuit is from November 6, 2024, to January 23, 2026 [2]. - Allegations include that the company did not timely or appropriately value its investments, and its portfolio restructuring efforts were ineffective [2]. - The lawsuit claims that the company's unrealized losses were understated and its net asset value was overstated, leading to misleading positive statements about its business and operations [2]. Group 2: Next Steps for Shareholders - Shareholders who purchased TCPC shares during the class period are encouraged to register for the class action by April 6, 2026, to potentially become lead plaintiffs [3]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's progress [3]. Group 3: Law Firm's Commitment - The Gross Law Firm is dedicated to protecting investors' rights and ensuring companies adhere to responsible business practices [4]. - The firm aims to recover losses for investors caused by false or misleading statements that inflated the company's stock price [4].

Core Viewpoint - Hagens Berman is notifying investors about a pending securities class action against StubHub Holdings, Inc. regarding undisclosed adverse trends in vendor payments that led to a significant decline in free cash flow following its September 2025 IPO [1][3]. Group 1: Legal Proceedings - The lead plaintiff deadline for the StubHub securities class action is set for January 23, 2026 [2]. - The lawsuit alleges that StubHub's IPO documents failed to disclose critical information about changes in vendor payment timing, which adversely affected liquidity [2][6]. - The investigation is focused on whether the company should have disclosed the vendor payment issues in its IPO documents [5]. Group 2: Financial Impact - StubHub reported a free cash flow decline of 143%, resulting in negative $4.6 million for the quarter following its IPO [4]. - The company's stock price dropped over 20% in a single day after the financial results were announced and has traded as much as 56% below its IPO price of $23.50 [4]. Group 3: Investor Communication - Investors who purchased StubHub securities during the September 2025 IPO and experienced losses are encouraged to contact Hagens Berman [2][8]. - The firm is also open to whistleblowers with non-public information regarding StubHub, offering potential rewards for information leading to successful recovery [7][8].

Core Points - A New York federal court has re-opened the lead plaintiff process in the Spectrum Pharmaceuticals (SPPI) securities class action, allowing new investors to apply by September 24, 2025 [1][2] - The class period for the lawsuit is from March 17, 2022, to September 22, 2022, and the case has survived a motion to dismiss [3][4] - The lawsuit alleges that Spectrum misled investors about the success of its cancer treatment drug, poziotinib, leading to a share price drop of over 37% when FDA concerns were revealed [3][4] Company Background - The federal class action, Christiansen v. Spectrum Pharmaceuticals, Inc., has been ongoing since late 2022, focusing on alleged misrepresentations regarding the efficacy of poziotinib [3][4] - Assertio Holdings (ASRT) acquired Spectrum Pharmaceuticals in July 2023, allowing investors who received ASRT shares post-acquisition to potentially represent the class [5] Legal Proceedings - The proceedings were previously stayed due to allegations of misconduct by the court-appointed lead plaintiff, which resulted in his disqualification [4] - Hagens Berman is actively encouraging investors who suffered significant losses to consider becoming the new lead plaintiff, emphasizing the importance of this role in overseeing litigation [6]

Core Viewpoint - A New York federal court has reopened the lead plaintiff process in the Spectrum Pharmaceuticals (SPPI) securities class action, allowing new investors to represent the class after the previous lead plaintiff was disqualified [1][4]. Group 1: Class Action Details - Investors who purchased Spectrum (SPPI) common shares during the Class Period (Mar. 17, 2022 – Sept. 22, 2022) and those who received shares of Assertio Holdings (ASRT) due to Assertio's acquisition of Spectrum may be eligible to represent the class [2][5]. - The federal class action, Christiansen v. Spectrum Pharmaceuticals, Inc., alleges that Spectrum misled investors about the success of its cancer treatment drug, poziotinib, leading to a share price drop of over 37% when FDA concerns were revealed [3][4]. Group 2: Legal Proceedings - The case has survived a motion to dismiss, and plaintiffs had moved for class certification, but proceedings were stayed due to allegations of misconduct by the court-appointed lead plaintiff [4]. - The new deadline for applying to be the lead plaintiff is September 24, 2025 [3]. Group 3: Hagens Berman's Role - Hagens Berman is actively investigating claims related to the case and encourages investors who suffered significant losses to consider becoming the new lead plaintiff [6]. - The firm has a history of representing investors and has secured over $2.9 billion in similar cases [7].

Group 1 - A New York federal court has re-opened the lead plaintiff process in the Spectrum Pharmaceuticals (SPPI) securities class action, allowing new investors to apply by September 24, 2025 [1][2] - The class period for the lawsuit is from March 17, 2022, to September 22, 2022, and the case has survived a motion to dismiss [3][4] - The lawsuit alleges that Spectrum misled investors about the success of its cancer treatment drug, poziotinib, leading to a share price drop of over 37% when FDA concerns were revealed [3][4] Group 2 - Assertio Holdings (ASRT) acquired Spectrum Pharmaceuticals in July 2023, allowing investors who received ASRT shares after acquiring SPPI shares during the class period to potentially represent the class [5] - Hagens Berman is encouraging investors who suffered significant losses to consider becoming the new lead plaintiff, emphasizing the importance of this role in overseeing litigation [6]